Loading experience... Please wait.
Integrating Circadian Rhythm and Neurobiology in Precision Medicine: A Novel Approach for Treating Severe Autism Through the Exploration of Time Cells and Genetic Mechanisms | Alona's Heritage Archive — 2
Background Image

Integrating Circadian Rhythm and Neurobiology in Precision Medicine: A Novel Approach for Treating Severe Autism Through the Exploration of Time Cells and Genetic Mechanisms

Directed evolution.

by P. De Ceuster — Posted in Publications on September 07, 2025

Background Image

TAG: #Publications
Latest edit: 15/01/24





Executive Overview & Research Foundations

Autism Spectrum Disorder (ASD) represents a complex, heterogeneous group of neurodevelopmental conditions characterized by alterations in reciprocal social interaction, verbal and non-verbal communication, and repetitive or restricted sensorimotor behaviors. In individuals presenting with severe phenotypes—frequently accompanied by intellectual disability, refractory epilepsy, and non-verbal status—conventional behavioural interventions frequently exhibit limited efficacy. Recent genomic discoveries, notably those elucidated by Silvia De Rubeis and the Autism Sequencing Consortium, demonstrate that severe autism is anchored in convergent molecular pathways: synaptic scaffold assembly, chromatin remodeling, transcriptional regulation, and localized protein synthesis.

Concurrently, advances in circadian neurobiology have established that the master biological clock—situated in the suprachiasmatic nucleus (SCN) of the hypothalamus—exercises pervasive regulatory control over neurogenesis, dendritic spine morphology, and synaptic plasticity. Circadian rhythms are maintained by cell-autonomous transcriptional–translational feedback loops (TTFLs) governed by the heterodimerization of CLOCK and BMAL1, which drive the expression of Period (PER1/2/3) and Cryptochrome (CRY1/2) genes. In neurotypical brains, these oscillatory cycles align cellular metabolism, neurotransmitter vesicle cycling, and excitatory–inhibitory (E/I) balance with environmental solar cues. In severe ASD, however, this coordination breaks down, leading to persistent chronobiological desynchronization.

Temporal Coding via Hippocampal Time Cells

A critical, previously under-explored dimension of ASD pathophysiology is the dysfunction of time cells—specialized pyramidal neurons located primarily within hippocampal CA1 and CA3 fields, the medial entorhinal cortex, and the medial prefrontal cortex (mPFC). Time cells fire sequentially during temporally structured delays or behavioral epochs, providing an internal neural metric of elapsed time independent of spatial position. Through theta-phase precession, time cells bridge sequential episodes, forming the fundamental substrate for working memory, narrative comprehension, and social-cognitive anticipation.

In individuals with severe ASD, hippocampal time-cell firing loses its disciplined phase-locking relative to ongoing local field potential (LFP) oscillations. This microcircuit temporal desynchrony impairs the ability to anticipate social interactions, encode episodic timelines, and parse speech streams. The master clock in the SCN provides tonic entrainment to these hippocampal oscillators via monoaminergic and peptidergic projections (including vasoactive intestinal peptide [VIP] and arginine vasopressin [AVP]). When circadian rhythmicity is compromised, time cells fail to sustain stable temporal sequences, driving profound sensory overload and cognitive fragmentation.

Molecular Pathways & Precision Chronopharmacology

The molecular interface between circadian gene expression and synaptic plasticity suggests novel therapeutic strategies. Melatoninergic dysregulation is prevalent in ASD, frequently linked to loss-of-function variants in ASMT (acetylserotonin O-methyltransferase) and AANAT (aralkylamine N-acetyltransferase). Beyond its role in sleep induction, melatonin acts through high-affinity G-protein coupled receptors (MT1 and MT2) to modulate cAMP/PKA phosphorylation cascades, suppressing hyperactive NMDA receptor-mediated calcium influx and preventing excitotoxic dendritic spine elimination.

Furthermore, chronopharmacological targeting of circadian feedback loops provides a mechanism to restore excitation/inhibition equilibrium. Precision administration of MT2-selective agonists, combined with chronologically timed positive allosteric modulators of GABAA receptors and small-molecule modulators of casein kinase 1ε (CK1ε), optimizes drug bioavailability during specific circadian gate windows. This precision approach stabilizes time-cell firing rhythms, restores synaptic homeostasis, and addresses the root molecular etiology of severe autism.

📖 Monograph Chapters & Dedicated Sections

Explore each section of the complete academic investigation:

Official Publication & Archival Record

Integrating Circadian Rhythm and Neurobiology in Precision Medicine: A Novel Approach for Treating Severe Autism Through the Exploration of Time Cells and Genetic Mechanisms

Author: Peter De Ceuster • SIG Labs Research Monograph • Published: September 07, 2025 • Open Access Preprint

Citation: De Ceuster, P. (2025). Integrating Circadian Rhythm and Neurobiology in Precision Medicine: A Novel Approach for Treating Severe Autism Through the Exploration of Time Cells and Genetic Mechanisms. SIG Labs. DOI: 10.5281/zenodo.17074161. Full text available at work/circ (1).pdf.

© Peter De Ceuster • SIG Labs • All rights reserved.

Mobile detected. For search functionality, PDF printing, or EyeFriendly Mode, please switch to desktop.
Legal Notice